T-Control® Highlighted by Fenin MAY 2025

Thank you to Fenin for recognizing our solution, T-Control®, as part of their ongoing commitment to driving innovation in healthcare.

At Rethink Medical, we believe innovation must go beyond clinical validation — real impact happens when startups, hospitals, and industry leaders collaborate early to create meaningful change in patients' lives.

T-Control® was born from frontline clinical experience, with the goal of reducing infections, enhancing patient autonomy, and lightening the workload for healthcare professionals.

Let’s keep pushing boundaries, together.

Sharing the T-Control® Journey at the ENFURO Annual Congress MAY 2025

At Rethink Medical, we’re proud and grateful for the opportunity to share the story behind T-Control® during the annual congress of ENFURO.

This event gave us the chance to present how a clinical need identified in everyday nursing practice inspired the development of an innovative medical device — one that today offers a real solution to improve both patient outcomes and clinical efficiency.
​
We thank ENFURO for creating a space where innovation driven by healthcare professionals can be recognized, discussed, and celebrated.

T-Control® Achieves CE Mark Certification MAY 2025

We are thrilled to announce that our T-Control® urinary catheter has officially received the CE Mark, certifying its compliance with European safety and performance standards.

This milestone is the result of years of dedication, research, and a shared mission: to improve patient quality of life, support healthcare professionals, and reduce environmental impact in hospital settings.
Designed with real clinical practice in mind, T-Control® provides a unique solution to address key challenges associated with one of the most widely used medical devices: the urinary catheter.
​
A heartfelt thank you to our team, partners, and collaborators who made this achievement possible — we’re just getting started!

Abstract Accepted at the XLIV AES Health Economics Conference MAR 2025

We continue the week with good news!
Our abstract has been approved for presentation at the XLIV Health Economics Conference, organised by the Spanish Health Economics Association (AES). We will be presenting an economic model designed to assess the financial impact of our T-Control® urinary catheter.

A huge thank you to Syreon Research Institute and Oriol Solá-Morales for all their collaboration.

Abstracts list

New Study Published in IJUN DEC 2024

We are proud to announce the publication of one of our latest studies in the prestigious International Journal of Urological Nursing (IJUN). This work marks another milestone in our commitment to advancing scientific research and improving clinical practices in urology and healthcare.
The study highlights our dedication to innovation and excellence, contributing valuable insights to the global medical community. You can access the full article here.
We are grateful to our team for their outstanding efforts and to our partners and collaborators for their continued support. Together, we are making strides toward a better future in healthcare.

Dr. José Medina Polo Presents Advances of T-Control® at the International Continence Society Congress OCT 2024

We had the privilege of having Dr. Jose Medina Polo present the accepted poster at the International Continence Society (ICS) , where we shared the preliminary results of T-Control®. We are proud to show that we are already seeing a significant improvement in the quality of life of our patients. An important step towards enhancing the well-being of those who need it most!

​#T-Control® #QoL #Health

Published our new study "Practices related to bladder catheterization: A survey of Spanish healthcare professionals" OCT 2024

We are pleased to announce the publication of our study titled "Practices Related to Urinary Catheterization: A Survey of Spanish Healthcare Professionals" in Enfuro magazine. This study provides an in-depth look at the practices, experiences, and challenges faced by healthcare professionals in Spain regarding urinary catheterization, a fundamental technique in patient care. The survey highlights key aspects of current training and protocols, offering valuable data to enhance safety and efficiency in healthcare practices.
Read the full article for more details: read article.

La Razón Highlights Our T-Control® Project and Funding Round. AGO 2024

We are pleased to announce that the newspaper La Razón has published a detailed article about our innovative T-Control® project. The article discusses our technology and also highlights our recent funding round.

It explores the advancements we have made with our urinary catheter, as well as the positive impact we hope to have on the healthcare sector. Additionally, it covers the importance of the funding round in continuing to develop and expand our solution.

We are grateful to La Razón for the coverage and recognition.
​
You can read the full article here to learn more about our project and our next steps!

El Español publishes an article on Rethink Medical. AGO 2024

We are excited to share that the newspaper El Español has published an article highlighting our company. The article covers the market launch of our urinary catheter in 2025.
​
We thank El Español for the coverage and all our collaborators for their continued support.

Read the full article here and learn more about our work and vision!

Published our new study "Comparative study of in vitro Biofilm formation". JUL 2024

Another article is published about our results. Biofilm formation is one of the primary root causes of catheter-related urinary tract infections. In this study, we demonstrated that thanks to the novel design of the T-Control® catheter, which mimics the natural functioning of the urinary tract, the formation of biofilms can be prevented or delayed. We achieved this without applying any specific coating materials, thus avoiding other potential adverse effects.

Read the full article

Published our new study on urinary catheterization performed by nursing students. JUL 2024

Our new study about urinary catheterization done by nursing students is published. A direct comparison between the common Foley catheter and T-Control® gives us an insight about the difficulties of the insertion technique and the way we can improve protocol adherence. T-Control® catheter was the best-rated device in both the individual and the comparative questions. Most of the students would choose T-Control® for their future patients.

Full article

Special thanks to Universidad de Las Palmas de Gran Canaria for their invaluable support in making this study possible.

Our abstract has been accepted for ICS 2024, which will be held in Madrid. JUL 2024

Finally, the first clinical study results with our T-Control urinary catheter will be presented in public, at the International Continence Society´s Congress 2024, in Madrid. We are happy to have the chance to connect with attendees from all around the world. A huge step towards making T-Control available for patients soon.

Abstract ICS 2024

#ICS2024

Rethink Medical among the 6 chosen for the Emprende inHealth program by Lilly and Unlimited  JUL 2024

The inHealth program by Lilly and Unlimit begins its 9th edition. In this edition, they will support six projects, including Rethink Medical with the T-Control urinary catheter.
We thank Unlimited for the opportunity to participate in this program, and Lilly Spain for opening their doors and making social impact a fundamental principle, not only in their strategic company proposal but also in the daily lives of their employees.
Congratulations to all the selected projects!
​
Emprende In Health

Rethink Medical on the way to the SESSEP National Congress. MAR 2024

We look forward to seeing you at the National Congress of SESSEP with the motto: "Educating through simulation to improve and innovate in Health." We are delighted to present the results of our Living Lab with the T-Control urinary catheter.

Congreso Nacional de Sociedad Española de Simulación Clínica y Seguridad del Paciente.

Szilvia Endrényi: "Contributing to a better world in healthcare sector is what motivates us the most" FEB 2024​

We're delighted to share our latest press coverage! After being recognised as one of Spain's top 100 startups by the APTE, our CEO, Szilvia Endrényi, was interviewed by InnovaSpain where she shared our passion for enhancing the healthcare sector. Discover more about our vision and mission in this interview.
​
Read more

Rethink Medical represented at the III Biomedical and Health Research Conference of the Canary Islands FEB 2024

The junior researcher and biomedical from Rethink Medical, Clara Armas, stood out at the III Biomedical and Health Research Conference of the Canary Islands 2024, an event organized by the University of Las Palmas de Gran Canaria. The conference, held over two days on February 1st and 2nd, 2024, brought together prominent professionals and experts in the biomedical field.

Clara Armas, representing Rethink Medical, actively participated in the event, contributing to the exchange of knowledge and experiences in the field of biomedical research. The presence of our startup at this conference emphasizes our ongoing commitment to scientific progress and innovation in the healthcare sector.

Rethink Medical Recognised as One of the Top 100 Startups of 2023 by the Association of Sience and Technology Parks of Spain (APTE) ENE 2024

The Association of Science and Technology Parks of Spain (APTE) has unveiled its annual list of the top 100 startups of 2023, showcasing excellence and innovation in the emerging business landscape across its 51 science and technology parks in 15 Spanish autonomous communities.

Among the distinguished companies, Rethink Medical is proud to be acknowledged as one of the standout performers, not only ranking among the top 100 startups but also being one of the 32 startups led by women. This dual recognition underscores Rethink Medical's commitment to diversity and excellence in innovation.

The list compiled by APTE aims to highlight the quality and entrepreneurial capability thriving in Spain's science and technology parks. Rethink Medical, with its pioneering focus on innovation in medical devices through our revolutionary T-Control urinary catheter, has demonstrated exceptional growth potential and a significant contribution to the business landscape.

Moreover, the recognised startups will have the opportunity to showcase their innovations at the prestigious Transfiere Forum, taking place in Malaga from the 20th to the 22nd of March 2024. This event will provide Rethink Medical with a unique platform to present its advancements and establish valuable connections with industry leaders, investors, and other key stakeholders.

Rethink Medical extends gratitude to APTE for this honour and is committed to continuing to lead innovation in the field of medical device development, addressing the most pressing challenges in our society.

Read More

Rethink Medical in FORBES! ENE 2024

We start 2024 with good news! We have been selected among the 24 Changemakers for 2024 by FORBES magazine in Spain. Without a doubt, this year we hope to give great news!! 

European Association of Urology Nurses Paris 2024​​

See you at EAUN24 where our work around urinary catheterization will be presented. Interesting results from our survey in Sweden.

Rethink Medical Clinches Top Prize at "Canarias Destination Startup Oct 2023

In a thrilling event held at the prestigious Alfredo Kraus Auditorium, our company, Rethink Medical, stood out among the best startups in the final of "Canarias Destination Startup." After an intense first round of pitch contests, with around 30 promising companies participating, we qualified to compete in the final against the best regional, national, and international startups in the competition.

This year, the competition gained special significance with several finalist companies in the healthcare sector, underscoring the importance of supporting initiatives that aim to improve health and well-being in society.

The stellar performance of Manuel Luque, representative of Rethink Medical, in the final stage of the competition not only captured the attention of the audience and judges but also secured our company the coveted first prize of the event. The accolade includes a cash prize of €10,000, generously awarded by the Cabildo de Gran Canaria, as well as €7,200 in services provided by Intelectium.

This triumph not only solidifies Rethink Medical's position in the business landscape but also highlights the talent and innovation present in the healthcare sector. Congratulations to all participating companies, and we extend our gratitude to the "Canarias Destination Startup" event for providing a platform that drives the growth and visibility of promising startups. We are thrilled by the recognition and committed to continuing our mission to transform healthcare through innovative solutions.

Rethink Medical at the Healthcare Investment Forum in Barcelona. Oct 2023

Szilvia Endrényi, co-founder and CEO of Rethink Medical, introduces our device T-Control® at the Healthcare Investment Forum of the Barcelona Medical College. The Healthcare Investment Forum in Barcelona has become a benchmark in the Catalan biomedical ecosystem, fostering innovation and entrepreneurship among the community, aiming to connect healthcare entrepreneurs with investors in the sector.

LSI Presentation: Our CEO Szilvia Endrényi on the Global State. Sept 2023

In September, our CEO, Szilvia Endrenyi, had the opportunity to showcase our company at the LSI event, a pivotal platform within the medical devices sector that, until recently, was primarily held in the United States.
Her presentation captured the attention of significant companies and individuals, encompassing potential future business collaborators, investors, and some technical service companies whose assistance can prove invaluable in FDA-related procedures.
​
Aside from conducting numerous meetings, presenting the project in front of a prominent audience, and garnering international exposure, we also seized the chance to connect with startups within the global innovative ecosystem of medical devices, sharing experiences and validating our model.

​Check out the video presentation.

New article published Jul 2023

Our article about possible improvements in urinary catheterization published. The role of nurses and the innovation in medical devices are key to improve work efficiency. Non aseptic insertion is one of the most important route causes of CAUTI.

Read our article here

Rethink Medical obtains significant funding through CDTI, as one of the best valued projects at the European level 
​Jun 2023

Rethink Medical has been awarded a 1.5 million euro grant from the Center for Industrial Technological Development (CDTI), ranking sixth with the highest score at the national level.

The medical innovation startup received this prestigious grant thanks to the Seal of Excellence achieved in the EIC Accelerator Program (Horizon Europe).
The duration will be two years and the funds will be used mainly for an international clinical trial and the certification of the company's first device, the T-Control® urinary catheter.
​
With this important achievement, Rethink Medical is in a privileged position to continue innovating in the field of health and medical technology, focused mainly on nursing, in which Manuel Luque, nurse and co-founder of the startup, has international experience.

#CDTI #Innovation #Health

New collaborations to shed more light on nursing May 2023

We started a new study in Belgium. We will soon see how our innovative T-Control® catheter can facilitate the work of midwives. In collaboration with Artevelde Academy, we evaluate the usability of T-Control® in a different, but equally relevant  environment.
The first midwives who had the opportunity to participate in the study have shown very good acceptance, both of the catheter itself, and of its accessory that facilitates the mobilization of patients,  offering a more comfortable alternative vs common devices.
​
#NextGenerationEU #CanariasavanzaconEuropa #SODECAN #FondoCanariasfinancia #UnionEuropea #GobiernodeCanarias​

Lets get ready to start our clinical essays May 2023

In May we visited the University Hospital of 12 de Octubre (Madrid), where we will soon begin one of our studies with the  T-Control urinary catheter. After all these years of development, the time has finally come for it to start being used in humans.

No doubt, moments of great excitement are coming!

#innovation #nursing #vesical probe #clinical study

Presentation at the European Congress of Urology  March 2023

Once again, we have been present at the European Urology Nursing Congress and at the European Urology Congress. On this occasion we were able to present an abstract at the UAE and a poster at the EAUN. At both congresses, T-Control® and the novelty it brings, generated great expectations and curiosity among the attendees.  More info

ISO 13485   May 2023

Undoubtedly, one of the most important milestones of the beginning of the year has been the achievement of the ISO 13485 quality certificate. It is a great step that confirms our commitment and quality of work, and brings us closer to obtaining the CE marking certificate to enter the European market soon.

Members at a discussion panel at the Patent Week  Sep 2022

We participated at the round table organized by the ULPGC during the Patent Week initiative, where some of the most representative innovative companies of the Canarian Islands had a chance to meet and discuss. It was undoubtedly great news to be able to see university students, start-ups, politicians and directors of the university gathered in the same room. Without a doubt, sharing our experience and know-how filled us with pride and pleasure.

New incorporation Aug 2022

Our company has been one of the only three companies in the Canary Islands to get a Research grant through the INVESTIGO program. This has allowed us have in our team a Subsidized Junior Researcher. Clara Armas, graduated in Biomedicine from the University of Seville and studies graduate degree at the University of Murcia.

Clara will help us in planning and carrying out studies of validation and will also participate in the exploration of possible new markets, such as the vet. 
This action is part of the "Recovery, transformation and resilience plan financed by the European Union through the Next Generation EU funds. 

Rethink Medical obtain funding from SODECAN  Jul 2022

Last Wednesday, July 27, the signing of the funding granted by SODECAN took place, for the amount of EIGHT HUNDRED AND FORTY-NINE THOUSAND FOUR HUNDRED AND FORTY-THREE EUROS (€849,443.00), to finance the project called “T- CONTROL®. INNOVATIVE URINARY CATHETER DESTINED TO REDUCE INFECTIONS, INCREASE THE QUALITY OF LIFE OF PATIENTS AND IMPROVE THE EFFICIENCY OF WORK IN THE HOSPITAL”.

The funding was granted within the framework of the Ordinary Loan Line for SME Business Innovation of the Canarias Financia 1 Fund, which aims to grant ordinary loans to help improve the competitiveness of Canarian SMEs by promoting their technological modernization, organization and business management, as well as the development and implementation of new processes and products in the Canary Islands.

Members at a panel discussion about innovation Jun 2022

We were invited to a panel discussion on the occasion of the conference “Emerging technology companies as an engine of innovation: Transforming collaboration between industry and knowledge agents”.

Many thanks to the Canarian Association of Start-up Emerge for having this great initiative. It was undoubtedly a great experience, as well as a great opportunity to exchange the way of seeing innovation from the different actors that intervene in the archipelago, among which were representatives of both universities, the Government of the Canary Islands, the Canary Islands Health Service and of large, medium and small companies.

European Urology Congress Jun 2022

Our CIO had the honor of being able to exhibit our Living Lab with T-Control® at the European Congress of Urology and the European Urology Congress of Nursing.  A great opportunity to show our device and the great benefits it brings, which were well received by the attending public.
​#UAE #Urology

EMPRENDEDORES Magazine Jun 2022

If you are in the world of entrepreneurship in Spain, you have undoubtedly heard of the Emprendedores magazine. Undoubtedly a national reference that this month has dedicated an article to our CEO Szilvia Endrenyi, where she shares some experiences and reflections on our company and first project, T-Control®.

For more info: Link 

Spanish Urology Congress Jun 2022

Proud to present our project at the AEU Congress hand in hand with Continentia Foundation. Thank you all for your contribution!

EATIC 2022 Feb 2022

An honor to have been one of the beneficiary companies in the #EATIC 2022 call. Thank you for your trust and support. We will continue contributing to the generation of knowledge and its application in real life.@agenciaiisi @Red_CIDE

Presenters at the EAU  Jan 2022

Improvements in indwelling bladder catheterization. Honoured to present our study at the “Affordable techniques in urology” session at the #EAU22 Congress. ⁦Thanks to the European Association of Urology (EAU), Healthcare Living Lab Catalonia, EIT Health and CIMTI
For more info: Link 

Click here to edit.

---

Semifinalist in Innostar awards   May 2021

One more recognition for this project that makes us among the semi-finalists of Innostar Awards 2021. Regardless of whether or not we reached the finals, we are very grateful to have received this award from an institution of such reputation as Eit Health.
​For more info: Link

Winner of pitching event   February 2021

We are very happy to announce that we have won the pitching event held among the 15 projects that have participated in the Mentorday acceleration program, an accelerator promoted by ENDESA​

CSC Forum “Sanitary products and other medical devices in the context of the COVID-19 pandemic"  January 2021

Our invitation to this  forum organised by  the Consortium of Health and Social of Catalonia turned out to be a success. After our pitching, the attendees rated our company very positively. 92% agreed that T-Control® is a very interesting project.

EIT Health support for pre-clinical validation  August 2020

Many thanks for the EIT Health grant approved for our Living Lab activities with nurses! Stay tuned for the update!

Superiority vs gold standard demonstrated by in-vitro model  July 2020

Biofilm creation - among others -  is one of the most important factors linked to infections and almost the only one that can be measured through simulation. 
T-Control® demonstrated superiority vs gold standard, i.e. significant differences were observed between the biofilm quantity generated on the product´s surface.
This result reinforces the hypothesis that T-Control®, with it´s multifactorial approach towards infection prevention addressing several route-causes at the same time, has high chances to show significant benefits in clinical settings. 

Validation through Patient Journey Mapping  March 2020

​​Wearing a urinary catheter represents a huge challenge for patients, with Quality of Life implications right from the first moment. Catheter-related Quality of Life studies are scarce, so we decided to organize a specific workshop with patients from different clinical backgrounds in order to openly talk about their experience.

We also managed to introduce the T-Control® concept to the participants and analyze the added value of the product in the whole Patient Journey.
Many thanks for our partners, IEXP Patient Experience Institute  and Asociación Continentia  for the collaboration.
Results to be published soon!

---

Winner of the Entrepreneur Awards Mapfre Guanarteme and FULP 2019

Once again, we are on the newspaper.  We are happy to inform that we have been selected as one of the winners of the Entrepreneur Awards organized by  FUNDACION MAPFRE Guanarteme  and the University´s Foundation of Las Palmas.
We are very grateful for this recognition of the effort and perseverance. We really appreciate all the trust  placed in us.  #entrepreneurship #awards

For more info: Link

Among the best projects ​WER 2019 

Very pleased to be one of the 30 selected #FemaleEntrepreneurs with one of the few medicaldevices and the only tangible product at the WER19 event in Madrid. This event is one of the most important initiatives to support women entrepreneurs and give  visibility  to the projects that they are leading.

For more info: Link

Great reception of T-Control® ​Healthio 2018 

T-Control® received an extremely positive feedback at HealthIO Global 2018, one of the most important events in Europe in the medical innovation field. It brings together patients, healthcare professionals and innovators in order to understand each other´s needs and find innovative solutions. T-Control® was specially appreciated by nurses who clearly see the advantages it can offer them and their patients on a day to day basis.  

​For more information: ​ Link

SME Instrument granted  ​Horizon2020 

2018 June starts with good news! We have been granted an SME Phase I Instrument grant, as part of  European initiatives  supporting innovation.  More and more opportunities are helping us bring our idea to market place! 

For more information:  Link

Second round!  MassChallenge 

​We have been selected for the 2nd round of the very demanding selection process of  MassChallenge, Boston. Out of 1.700 projects presented,  300 got to this phase. We are very proud of our work!

For more information:  Link

Acceleration!  Cimti 2018

The first days of 2018 have brought us very good news! T- Control ®, has been selected to be part of the accelarator program of Cimti (Center for the Integration of Medicine and Innovative Technologies in Catalonia).
For more information:  Link

European Funds  Eit Health 2017

It is an honour to be able to announce that Rethink Medical was selected as one of the 5 best projects submitted to the EIT Health Headstart competition  in Spain, which is It is a highly prominent organisation. Thank you very much to all those who contributed to make this happen!
For more information:  Link

Investor Forum  Forum HealthCare 2017

On 23rd February we had the opportunity to be one of the 10 startups presenting at the  18th Investment Forum Healthcare Barcelona, organised by ESADE Business Angel Network, Barcelona Physicians Association, Barcelona Activa - Barcelona City Council and Biocat.
bit.ly/2lJe5Eu #ForumHealthcare

New partner  Continentia Association

In January  2017 we signed a collaboration agreement with Continentia Association. The Association, created by a group of specialists in the field of urology,  focused on research of incontinence-related diseases and professional training in this field. Incorporating their experience and extensive knowledge is a great value to us.

Dr. José Emilio Batista, president of the Association, is a well-reputed urologist with international experience. He is a scientific researcher, author of several articles in international and national publications, speaker at professional congresses and training programs and holder of the prize for Professional Excellence of the Medical Society of Barcelona.